Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2019

Open Access 01-12-2019 | Cough | Research

SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics

Authors: Sau-nga Fu, Man-Chi Dao, Carlos King-Ho Wong, Wai-cho Yu

Published in: Health and Quality of Life Outcomes | Issue 1/2019

Login to get access

Abstract

Introduction

The aim of this paper is to find out generic preference-based Short-Form 6 Dimensions (SF-6D) utility scores of smokers and ex-smokers with varying cigarette exposure, with and without respiratory symptoms.

Methods

Seven hundred thirty one people aged ≥30 with a history of smoking who attended 5 public primary care clinics completed a cross-sectional survey using SF-6D utility score, Breathlessness, Cough, and Sputum Scale (BCSS©) and office spirometry.

Results

Most of the subjects were men (92.5%) in an older age group (mean age 62.2 ± 11.7 years). About half of them (48.3%) were current smokers while the other half (51.7%) were ex-smokers. More than half of them (54.2%) reported mild respiratory symptoms (mean BCSS score 0.95 ± 1.12). The most common symptoms were sputum (45.1%), followed by cough (34.2%) and breathlessness (6.0%). The SF-6D overall utility score was 0.850 ± 0.106. The subjects reported significantly lower SF-6D scores when they had breathlessness (0.752 ± 0.138; p = < 0.001), cough (0.836 ± 0.107; p = 0.007), sputum (0.838 ± 0.115; p = 0.004) or any of the above symptom (0.837 ± 0.113; p < 0.001). In both groups of current smokers and ex-smokers, there was no statistically significant difference in the scores among light, moderate or heavy smokers. In the Tobit regression model of factors affecting SF-6D utility score, subjects who reported more respiratory symptoms (i.e. higher BCSS©) had lower SF-6D scores (B = − 0.018 ± 0.007, p < 0.001), while men had higher SF-6D scores than women (B = 0.037 ± 0.031, p = 0.019). Subjects who attended middle or high school had higher SF-6D score than those attended the University or above. The presence of airflow obstruction was not associated with the score.

Conclusions

The study yielded SF-6D utility scores of smokers and ex-smokers with different reported cigarette exposure, which could be useful in future clinical studies and cost-effectiveness analysis.
Literature
1.
go back to reference Goldenberg M, Danovitch I, IsHak WW. Quality of life and smoking. Am J Addict. 2014;23(6):540–62.CrossRef Goldenberg M, Danovitch I, IsHak WW. Quality of life and smoking. Am J Addict. 2014;23(6):540–62.CrossRef
2.
go back to reference Tillmann M, Silcock J. A comparison of smokers’ and ex-smokers’ health-related quality of life. J Public Health Med. 1997;19(3):268–73.CrossRef Tillmann M, Silcock J. A comparison of smokers’ and ex-smokers’ health-related quality of life. J Public Health Med. 1997;19(3):268–73.CrossRef
3.
go back to reference Wilson D, Parsons J, Wakefield M. The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers. Prev Med. 1999;29(3):139–44.CrossRef Wilson D, Parsons J, Wakefield M. The health-related quality-of-life of never smokers, ex-smokers, and light, moderate, and heavy smokers. Prev Med. 1999;29(3):139–44.CrossRef
4.
go back to reference Hays JT, Croghan IT, Baker CL, Cappelleri JC, Bushmakin AG. Changes in health-related quality of life with smoking cessation treatment. Eur J Public Health. 2012;22(2):224–9.CrossRef Hays JT, Croghan IT, Baker CL, Cappelleri JC, Bushmakin AG. Changes in health-related quality of life with smoking cessation treatment. Eur J Public Health. 2012;22(2):224–9.CrossRef
5.
go back to reference Coste J, Quinquis L, D'Almeida S, Audureau E. Smoking and health-related quality of life in the general population. Independent relationships and large differences according to patterns and quantity of smoking and to gender. PLoS One. 2014;9(3):e91562.CrossRef Coste J, Quinquis L, D'Almeida S, Audureau E. Smoking and health-related quality of life in the general population. Independent relationships and large differences according to patterns and quantity of smoking and to gender. PLoS One. 2014;9(3):e91562.CrossRef
6.
go back to reference Axelsson M, Lindberg A, Kainu A, Ronmark E, Jansson SA. Respiratory symptoms increase health care consumption and affect everyday life - a cross sectional population-based study from Finland, Estonia, and Sweden. Eur Clin Respir J. 2016;27(3):31924. Axelsson M, Lindberg A, Kainu A, Ronmark E, Jansson SA. Respiratory symptoms increase health care consumption and affect everyday life - a cross sectional population-based study from Finland, Estonia, and Sweden. Eur Clin Respir J. 2016;27(3):31924.
7.
go back to reference Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, et al. Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirol. 2018;23(5):512–8.CrossRef Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, et al. Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirol. 2018;23(5):512–8.CrossRef
8.
go back to reference Voll-Aanerud M, Eagan TML, Plana E, Omenaas ER, Bakke PS, Svanes C, et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Qual Life Outcomes. 2010;8:107.CrossRef Voll-Aanerud M, Eagan TML, Plana E, Omenaas ER, Bakke PS, Svanes C, et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Qual Life Outcomes. 2010;8:107.CrossRef
9.
go back to reference Willemse BWM, Postma DS, Timens W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464–76.CrossRef Willemse BWM, Postma DS, Timens W, ten Hacken NHT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464–76.CrossRef
10.
go back to reference Martinez CH, Kim V, Chen Y, Kazerooni EA, Murray S, Criner GJ, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014;108(3):491–9.CrossRef Martinez CH, Kim V, Chen Y, Kazerooni EA, Murray S, Criner GJ, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014;108(3):491–9.CrossRef
11.
go back to reference Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, Fitzgerald JM, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax. 2014;69(8):709–17.CrossRef Tan WC, Bourbeau J, Hernandez P, Chapman KR, Cowie R, Fitzgerald JM, et al. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study. Thorax. 2014;69(8):709–17.CrossRef
12.
go back to reference Wheaton AG, Ford ES, Thompson WW, Greenlund KJ, PresleyCantrell LR, Croft JB. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States--National Health and nutrition examination survey 2007-2010. BMC Public Health. 2013;13:854.CrossRef Wheaton AG, Ford ES, Thompson WW, Greenlund KJ, PresleyCantrell LR, Croft JB. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States--National Health and nutrition examination survey 2007-2010. BMC Public Health. 2013;13:854.CrossRef
13.
go back to reference Guerra S, Carsin AE, Keidel D, Sunyer J, Leynaert B, Janson C, Jarvis D, Stolz D, Rothe T, Pons M, Turk A, Anto JM, Probst-Hensch N. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J. 2017;49(5):1602096. Guerra S, Carsin AE, Keidel D, Sunyer J, Leynaert B, Janson C, Jarvis D, Stolz D, Rothe T, Pons M, Turk A, Anto JM, Probst-Hensch N. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J. 2017;49(5):1602096.
14.
go back to reference Cheruvu VK, Odhiambo LA, Mowls DS, Zullo MD, Gudina AT. Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J COPD. 2016;11(1):2211–9.CrossRef Cheruvu VK, Odhiambo LA, Mowls DS, Zullo MD, Gudina AT. Health-related quality of life in current smokers with COPD: factors associated with current smoking and new insights into sex differences. Int J COPD. 2016;11(1):2211–9.CrossRef
15.
go back to reference Charafeddine R, Demarest S, Cleemput I, Van Oyen H, Devleesschauwer B. Gender and educational differences in the association between smoking and health-related quality of life in Belgium. Prev Med. 2017;105:280–6.CrossRef Charafeddine R, Demarest S, Cleemput I, Van Oyen H, Devleesschauwer B. Gender and educational differences in the association between smoking and health-related quality of life in Belgium. Prev Med. 2017;105:280–6.CrossRef
16.
go back to reference World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.CrossRef World Medical Association declaration of Helsinki. Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.CrossRef
17.
go back to reference GTSS Collaborative G. The global tobacco surveillance system. Tob Control. 2006;15(Suppl 2):1–3. GTSS Collaborative G. The global tobacco surveillance system. Tob Control. 2006;15(Suppl 2):1–3.
18.
go back to reference Warren CW, Lee J, Lea V, Goding A, O'Hara B, Carlberg M, et al. Evolution of the global tobacco surveillance system (GTSS) 1998-2008. Glob Health Promot. 2009;16(2 Suppl):4–37.CrossRef Warren CW, Lee J, Lea V, Goding A, O'Hara B, Carlberg M, et al. Evolution of the global tobacco surveillance system (GTSS) 1998-2008. Glob Health Promot. 2009;16(2 Suppl):4–37.CrossRef
19.
go back to reference Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the breathlessness, cough and sputum scale. Respir Med. 2003;97(Suppl A):S59–70.CrossRef Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the breathlessness, cough and sputum scale. Respir Med. 2003;97(Suppl A):S59–70.CrossRef
20.
go back to reference Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRef Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.CrossRef
21.
go back to reference Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003;124(6):2182–91.CrossRef Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breathlessness, cough, and sputum scale: the development of empirically based guidelines for interpretation. Chest. 2003;124(6):2182–91.CrossRef
22.
go back to reference Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRef Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.CrossRef
23.
go back to reference Ware JEJ, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):903–12.CrossRef Ware JEJ, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):903–12.CrossRef
24.
go back to reference Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11(2):295–303.CrossRef Lam CL, Brazier J, McGhee SM. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health. 2008;11(2):295–303.CrossRef
25.
go back to reference McGhee SM, Schooling CM, Wong LC, Leung GM, Ho LM, Thomas GN, et al. Does smoking affect hospital use before death? A comparison of ever- and never-smokers in the last years of life. Med Care. 2008;46(6):614–9.CrossRef McGhee SM, Schooling CM, Wong LC, Leung GM, Ho LM, Thomas GN, et al. Does smoking affect hospital use before death? A comparison of ever- and never-smokers in the last years of life. Med Care. 2008;46(6):614–9.CrossRef
27.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, N MI, McKay R, Navajas D, OF P, Pellegrino R, Viegi G, Wanger J, ATS/ERS task force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, N MI, McKay R, Navajas D, OF P, Pellegrino R, Viegi G, Wanger J, ATS/ERS task force. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRef
28.
go back to reference Ip MS, Ko FW, Lau AC, Yu WC, Tang KS, Choo K, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384–92.CrossRef Ip MS, Ko FW, Lau AC, Yu WC, Tang KS, Choo K, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384–92.CrossRef
29.
go back to reference Arostegui I, NunezAnton V, Quintana JM. Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life. Stat Methods Med Res. 2012;21(2):189–214.CrossRef Arostegui I, NunezAnton V, Quintana JM. Statistical approaches to analyse patient-reported outcomes as response variables: an application to health-related quality of life. Stat Methods Med Res. 2012;21(2):189–214.CrossRef
30.
go back to reference Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–6.CrossRef Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–6.CrossRef
33.
go back to reference Wong CKH, Mulhern B, Cheng GHL, Lam CLK. SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018;27(9):2349–59.CrossRef Wong CKH, Mulhern B, Cheng GHL, Lam CLK. SF-6D population norms for the Hong Kong Chinese general population. Qual Life Res. 2018;27(9):2349–59.CrossRef
Metadata
Title
SF-6D utility scores of smokers and ex-smokers with or without respiratory symptoms attending primary care clinics
Authors
Sau-nga Fu
Man-Chi Dao
Carlos King-Ho Wong
Wai-cho Yu
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2019
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-019-1115-z

Other articles of this Issue 1/2019

Health and Quality of Life Outcomes 1/2019 Go to the issue